Literature DB >> 20188704

Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors.

Eduard Yakubov1, Gidi Rechavi, Shmuel Rozenblatt, David Givol.   

Abstract

Reprogramming of differentiated cells into induced pluripotent cells (iPS) was accomplished in 2006 by expressing four, or less, embryonic stem cell (ESC)-specific transcription factors. Due to the possible danger of DNA damage and the potential tumorigenicity associated with such DNA damage, attempts were made to minimize DNA integration by the vectors involved in this process without complete success. Here we present a method of using RNA transfection as a tool for reprogramming human fibroblasts to iPS. We used RNA synthesized in vitro from cDNA of the same reprogramming four transcription factors. After transfection of the RNA, we show intracellular expression and nuclear localization of the respective proteins in at least 70% of the cells. We used five consecutive transfections to support continuous protein expression resulting in the formation of iPS colonies that express alkaline phosphatase and several ESC markers and that can be expanded. This method completely avoids DNA integration and may be developed to replace the use of DNA vectors in the formation of iPS. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20188704     DOI: 10.1016/j.bbrc.2010.02.150

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  88 in total

Review 1.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

2.  Induced Pluripotent Stem Cells-A New Foundation in Medicine.

Authors:  George T-J Huang
Journal:  J Exp Clin Med       Date:  2010-10-22

3.  Efficient generation of nonhuman primate induced pluripotent stem cells.

Authors:  Bonan Zhong; Grant D Trobridge; Xiaobing Zhang; Korashon L Watts; Aravind Ramakrishnan; Martin Wohlfahrt; Jennifer E Adair; Hans-Peter Kiem
Journal:  Stem Cells Dev       Date:  2011-02-01       Impact factor: 3.272

4.  Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease.

Authors:  Abdul Jalil Rufaihah; Ngan F Huang; Sina Jamé; Jerry C Lee; Ha N Nguyen; Blake Byers; Abhijit De; Janet Okogbaa; Mark Rollins; Renee Reijo-Pera; Sanjiv S Gambhir; John P Cooke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 5.  Stem Cells in Skeletal Tissue Engineering: Technologies and Models.

Authors:  Mark T Langhans; Shuting Yu; Rocky S Tuan
Journal:  Curr Stem Cell Res Ther       Date:  2016       Impact factor: 3.828

Review 6.  Research on induced pluripotent stem cells and the application in ocular tissues.

Authors:  Xiao-Ling Guo; Jian-Su Chen
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

Review 7.  Induced pluripotent stem cells: origins, applications, and future perspectives.

Authors:  Jing Zhao; Wen-jie Jiang; Chen Sun; Cong-zhe Hou; Xiao-Mei Yang; Jian-gang Gao
Journal:  J Zhejiang Univ Sci B       Date:  2013-12       Impact factor: 3.066

8.  Safeguarding nonhuman primate iPS cells with suicide genes.

Authors:  Bonan Zhong; Korashon L Watts; Jennifer L Gori; Martin E Wohlfahrt; Joerg Enssle; Jennifer E Adair; Hans-Peter Kiem
Journal:  Mol Ther       Date:  2011-05-17       Impact factor: 11.454

9.  In vitro synthesis of modified mRNA for induction of protein expression in human cells.

Authors:  Meltem Avci-Adali; Andreas Behring; Heidrun Steinle; Timea Keller; Stefanie Krajeweski; Christian Schlensak; Hans P Wendel
Journal:  J Vis Exp       Date:  2014-11-13       Impact factor: 1.355

10.  Mouse embryonic stem cells have underdeveloped antiviral mechanisms that can be exploited for the development of mRNA-mediated gene expression strategy.

Authors:  Ruoxing Wang; Chengwen Teng; Joseph Spangler; Jundi Wang; Faqing Huang; Yan-Lin Guo
Journal:  Stem Cells Dev       Date:  2013-12-20       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.